Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • loretta.manning
    Member
    • Mar 2012
    • 20

    #1

    eSeminar June 18th

    Join us for an eSeminar June 18th, Introducing the HaloPlex Next Generation Sequencing Panels Targeting Cancer and Inherited Diseases for Research

    Learn More: http://bit.ly/173qCGw

    eSeminar description: The ability to detect sequence level variations through next generation sequencing in a fast, cost effective application has revolutionized the field of genetics. In order to harness the power of next generation sequencing for specific disease states, it is critical to target these specific genomic regions. Developed in conjunction with clinical research industry leaders, Agilent Technologies offers HaloPlex next generation sequencing target enrichment panels for researching specific genetic disorders.

    Agilent’s integrated solution for clinical genomics research also includes SureCall, an easy-to-use desktop application that combines best in class open source algorithms for end-to-end NGS data analysis from alignment to categorization of mutations. With this complete workflow, customers can rapidly deploy studies for clinical research.

    eSeminar presenters: Sheila Purim, Product Manager, Agilent Technologies and Anniek De Witte, Product Manager, CGH and NGS Software, Agilent Technologies, Inc.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-13-2026, 12:22 PM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-11-2026, 10:35 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
50 views
0 reactions
Last Post SEQadmin2  
Working...